In conclusion, the present study has demonstrated that detection of humoral immune responses to EGFR-derived peptides in plasma using the Luminex suspension array system may be a promising method for not only detecting the presence of EGFR mutations but also the prognostication of NSCLC patients receiving EGFR-TKIs. This evidence concerns the gene EGFR and non-small cell lung carcinoma.